vs
Priority Technology Holdings, Inc.(PRTH)とSotera Health Co(SHC)の財務データ比較。上の社名をクリックして会社を切り替えられます
Sotera Health Coの直近四半期売上が大きい($303.4M vs $247.1M、Priority Technology Holdings, Inc.の約1.2倍)。Sotera Health Coの純利益率が高く(11.5% vs 3.6%、差は7.9%)。Priority Technology Holdings, Inc.の前年同期比売上増加率が高い(8.8% vs 4.6%)。Sotera Health Coの直近四半期フリーキャッシュフローが多い($52.4M vs $30.9M)。過去8四半期でSotera Health Coの売上複合成長率が高い(10.6% vs 9.6%)
Priority Technology Holdings, Inc.は情報技術分野に注力する企業で、コンピューターや通信システムをはじめとする情報関連機器を軸に、情報の作成、処理、保存、検索、伝送といった情報技術関連の応用サービスを手がけ、コンピューターサイエンスと工学技術を基盤に事業を展開しています。
Sotera Health Coは医療安全ソリューションをグローバルに提供する企業で、医療機器メーカー、製薬会社、食品・消費財企業を対象に滅菌サービス、分析検査、規制対応コンサルティングを提供し、顧客の製品安全性確保と基準準拠を支援しています。
PRTH vs SHC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $247.1M | $303.4M |
| 純利益 | $8.9M | $34.8M |
| 粗利率 | — | 54.7% |
| 営業利益率 | 13.6% | 23.2% |
| 純利益率 | 3.6% | 11.5% |
| 売上前年比 | 8.8% | 4.6% |
| 純利益前年比 | 23.9% | 182.8% |
| EPS(希薄化後) | $0.10 | $0.12 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $247.1M | $303.4M | ||
| Q3 25 | $241.4M | $311.3M | ||
| Q2 25 | $239.8M | $294.3M | ||
| Q1 25 | $224.6M | $254.5M | ||
| Q4 24 | $227.1M | $290.2M | ||
| Q3 24 | $227.0M | $285.5M | ||
| Q2 24 | $219.9M | $276.6M | ||
| Q1 24 | $205.7M | $248.2M |
| Q4 25 | $8.9M | $34.8M | ||
| Q3 25 | $27.6M | $48.4M | ||
| Q2 25 | $10.9M | $8.0M | ||
| Q1 25 | $8.3M | $-13.3M | ||
| Q4 24 | $7.2M | $12.3M | ||
| Q3 24 | $10.6M | $17.0M | ||
| Q2 24 | $994.0K | $8.8M | ||
| Q1 24 | $5.2M | $6.3M |
| Q4 25 | — | 54.7% | ||
| Q3 25 | — | 57.0% | ||
| Q2 25 | — | 56.6% | ||
| Q1 25 | — | 53.2% | ||
| Q4 24 | — | 56.6% | ||
| Q3 24 | — | 55.4% | ||
| Q2 24 | — | 55.2% | ||
| Q1 24 | — | 51.2% |
| Q4 25 | 13.6% | 23.2% | ||
| Q3 25 | 15.6% | 23.4% | ||
| Q2 25 | 15.6% | 6.4% | ||
| Q1 25 | 14.5% | -5.8% | ||
| Q4 24 | 15.0% | 30.0% | ||
| Q3 24 | 16.8% | 28.2% | ||
| Q2 24 | 15.1% | 27.8% | ||
| Q1 24 | 13.6% | 21.4% |
| Q4 25 | 3.6% | 11.5% | ||
| Q3 25 | 11.4% | 15.5% | ||
| Q2 25 | 4.5% | 2.7% | ||
| Q1 25 | 3.7% | -5.2% | ||
| Q4 24 | 3.2% | 4.2% | ||
| Q3 24 | 4.7% | 6.0% | ||
| Q2 24 | 0.5% | 3.2% | ||
| Q1 24 | 2.5% | 2.5% |
| Q4 25 | $0.10 | $0.12 | ||
| Q3 25 | $0.34 | $0.17 | ||
| Q2 25 | $0.14 | $0.03 | ||
| Q1 25 | $0.10 | $-0.05 | ||
| Q4 24 | $-0.05 | $0.05 | ||
| Q3 24 | $0.07 | $0.06 | ||
| Q2 24 | $-0.23 | $0.03 | ||
| Q1 24 | $-0.10 | $0.02 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $77.2M | $344.6M |
| 総負債低いほど良い | $1.0B | $2.1B |
| 株主資本純資産 | $-100.4M | $606.0M |
| 総資産 | $2.4B | $3.3B |
| 負債/資本比率低いほどレバレッジが低い | — | 3.53× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $77.2M | $344.6M | ||
| Q3 25 | $57.0M | $299.2M | ||
| Q2 25 | $50.6M | $332.4M | ||
| Q1 25 | $47.6M | $304.4M | ||
| Q4 24 | $58.6M | $277.2M | ||
| Q3 24 | $41.1M | $306.7M | ||
| Q2 24 | $34.6M | $246.1M | ||
| Q1 24 | $34.3M | $261.1M |
| Q4 25 | $1.0B | $2.1B | ||
| Q3 25 | $997.5M | $2.1B | ||
| Q2 25 | $917.0M | $2.2B | ||
| Q1 25 | $918.9M | $2.2B | ||
| Q4 24 | $920.9M | $2.2B | ||
| Q3 24 | $808.1M | $2.2B | ||
| Q2 24 | $809.0M | $2.2B | ||
| Q1 24 | $631.4M | $2.2B |
| Q4 25 | $-100.4M | $606.0M | ||
| Q3 25 | $-110.3M | $550.5M | ||
| Q2 25 | $-146.1M | $511.3M | ||
| Q1 25 | $-158.3M | $414.1M | ||
| Q4 24 | $-166.8M | $404.9M | ||
| Q3 24 | $-165.8M | $470.2M | ||
| Q2 24 | $-172.1M | $422.8M | ||
| Q1 24 | $-159.9M | $429.4M |
| Q4 25 | $2.4B | $3.3B | ||
| Q3 25 | $2.2B | $3.2B | ||
| Q2 25 | $2.0B | $3.2B | ||
| Q1 25 | $1.9B | $3.1B | ||
| Q4 24 | $1.8B | $3.1B | ||
| Q3 24 | $1.8B | $3.1B | ||
| Q2 24 | $1.7B | $3.1B | ||
| Q1 24 | $1.6B | $3.1B |
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.89× | ||
| Q2 25 | — | 4.34× | ||
| Q1 25 | — | 5.36× | ||
| Q4 24 | — | 5.49× | ||
| Q3 24 | — | 4.73× | ||
| Q2 24 | — | 5.26× | ||
| Q1 24 | — | 5.19× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $36.8M | $103.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $30.9M | $52.4M |
| FCFマージンFCF / 売上 | 12.5% | 17.3% |
| 設備投資強度設備投資 / 売上 | 2.4% | 16.7% |
| キャッシュ転換率営業CF / 純利益 | 4.12× | 2.96× |
| 直近12ヶ月FCF直近4四半期 | $75.1M | $149.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $36.8M | $103.1M | ||
| Q3 25 | $36.1M | $71.2M | ||
| Q2 25 | $17.1M | $57.4M | ||
| Q1 25 | $10.0M | $55.5M | ||
| Q4 24 | $23.8M | $55.7M | ||
| Q3 24 | $19.8M | $97.5M | ||
| Q2 24 | $28.7M | $61.3M | ||
| Q1 24 | $13.3M | $9.7M |
| Q4 25 | $30.9M | $52.4M | ||
| Q3 25 | $30.1M | $35.0M | ||
| Q2 25 | $9.2M | $26.2M | ||
| Q1 25 | $4.9M | $35.6M | ||
| Q4 24 | $19.1M | $-10.2M | ||
| Q3 24 | $14.5M | $61.1M | ||
| Q2 24 | $23.6M | $19.4M | ||
| Q1 24 | $6.7M | $-25.2M |
| Q4 25 | 12.5% | 17.3% | ||
| Q3 25 | 12.5% | 11.2% | ||
| Q2 25 | 3.8% | 8.9% | ||
| Q1 25 | 2.2% | 14.0% | ||
| Q4 24 | 8.4% | -3.5% | ||
| Q3 24 | 6.4% | 21.4% | ||
| Q2 24 | 10.7% | 7.0% | ||
| Q1 24 | 3.3% | -10.2% |
| Q4 25 | 2.4% | 16.7% | ||
| Q3 25 | 2.5% | 11.6% | ||
| Q2 25 | 3.3% | 10.6% | ||
| Q1 25 | 2.3% | 7.8% | ||
| Q4 24 | 2.0% | 22.7% | ||
| Q3 24 | 2.3% | 12.7% | ||
| Q2 24 | 2.3% | 15.2% | ||
| Q1 24 | 3.2% | 14.1% |
| Q4 25 | 4.12× | 2.96× | ||
| Q3 25 | 1.31× | 1.47× | ||
| Q2 25 | 1.57× | 7.21× | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 3.29× | 4.52× | ||
| Q3 24 | 1.87× | 5.73× | ||
| Q2 24 | 28.87× | 7.00× | ||
| Q1 24 | 2.56× | 1.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
PRTH
セグメントデータなし
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |